RedHill Biopharma Receives U.S. Patent Allowance Covering Opaganib and RHB-107 Combination

NEXT STORY
Genmab Announces Financial Results for the First Nine Months of 2020
PREV STORY
Aptose to Present CG-806 and APTO-253 Data at the 2020 ASH Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Press release Biocartis Group NV: Biocartis and SkylineDx Sign Collaboration to Develop the Merlin Assay, a Test Predicting Risk for Nodal Metastasis in Melanoma, on Idylla™

author_avatar
NASDAQ Market News

MAC Clinical Research Announces Presentation at the 60th Annual Scientific Meeting of the American Headache Society

– New clinical trial data highlight potential of an evoked migraine model to test ...

author_avatar
NASDAQ Market News

Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

-  In the pivotal study, patients taking TAKHZYRO 300 mg every 2 weeks had an ...

author_avatar
NASDAQ Market News